Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study
Gespeichert in:
| Veröffentlicht in: | Transplantation proceedings 1999-02, Vol.31 (1-2), p.1142-1143 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1143 |
|---|---|
| container_issue | 1-2 |
| container_start_page | 1142 |
| container_title | Transplantation proceedings |
| container_volume | 31 |
| creator | Zanker, B Rothenpieler, U Kubitza, A Schneeberger, H Hillebrand, G Land, W |
| description | |
| doi_str_mv | 10.1016/S0041-1345(98)01938-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69635282</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134598019381</els_id><sourcerecordid>69635282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-7e2e12de0253a66514b4ef2653312a1bb4284ec3736c197480a9d1d05b191d173</originalsourceid><addsrcrecordid>eNqFkE1vFDEMhiNERZeFnwDKASGQGIiT-chwQaiiFKmFA3COMom3Dcwk0yRD2X9PtruC3jhZth7brx5CngB7DQzaN18Zq6ECUTcvevmSQS9kBffICmQnKt5ycZ-s_iLH5GFKP1jpeS0ekGNgTIoGYEVuPgfvcb6KIYffzryiPnidrzCGS_TO0Ek7n9Frb5DuxnreUufpT2c9bqsctU_zqAti6ayzQ58TXZLzl_Ti4rSagg-HrbdU09mNIdOUF7t9RI42ekz4-FDX5Pvph28nZ9X5l4-fTt6fV0b0LFcdcgRukfFG6LZtoB5q3PC2EQK4hmGouazRiE60Bvqulkz3FixrBujBQifW5Pn-7hzD9YIpq8klg2PJjGFJqu1b0XDJC9jsQRNDShE3ao5u0nGrgKmdcXVrXO10ql6qW-OlW5OnhwfLMKG9s7VXXIBnB0Ano8dNUWZc-sd1ddvJpmDv9hgWG78cRpVM0WnQuogmKxvcf5L8AavunoQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69635282</pqid></control><display><type>article</type><title>Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zanker, B ; Rothenpieler, U ; Kubitza, A ; Schneeberger, H ; Hillebrand, G ; Land, W</creator><creatorcontrib>Zanker, B ; Rothenpieler, U ; Kubitza, A ; Schneeberger, H ; Hillebrand, G ; Land, W</creatorcontrib><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/S0041-1345(98)01938-1</identifier><identifier>PMID: 10083511</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Cyclosporine - therapeutic use ; Drug Administration Schedule ; Drug toxicity and drugs side effects treatment ; Humans ; Immunomodulators ; Immunosuppressive Agents - administration & dosage ; Immunosuppressive Agents - pharmacokinetics ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation - immunology ; Medical sciences ; Middle Aged ; Mycophenolic Acid - administration & dosage ; Mycophenolic Acid - analogs & derivatives ; Mycophenolic Acid - pharmacokinetics ; Mycophenolic Acid - therapeutic use ; Pharmacology. Drug treatments ; Pilot Projects ; Tissue Donors ; Toxicity: urogenital system</subject><ispartof>Transplantation proceedings, 1999-02, Vol.31 (1-2), p.1142-1143</ispartof><rights>1999 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-7e2e12de0253a66514b4ef2653312a1bb4284ec3736c197480a9d1d05b191d173</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134598019381$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3536,23910,23911,25119,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1746785$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10083511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zanker, B</creatorcontrib><creatorcontrib>Rothenpieler, U</creatorcontrib><creatorcontrib>Kubitza, A</creatorcontrib><creatorcontrib>Schneeberger, H</creatorcontrib><creatorcontrib>Hillebrand, G</creatorcontrib><creatorcontrib>Land, W</creatorcontrib><title>Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cyclosporine - therapeutic use</subject><subject>Drug Administration Schedule</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Humans</subject><subject>Immunomodulators</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Immunosuppressive Agents - pharmacokinetics</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Transplantation - immunology</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycophenolic Acid - administration & dosage</subject><subject>Mycophenolic Acid - analogs & derivatives</subject><subject>Mycophenolic Acid - pharmacokinetics</subject><subject>Mycophenolic Acid - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Pilot Projects</subject><subject>Tissue Donors</subject><subject>Toxicity: urogenital system</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1vFDEMhiNERZeFnwDKASGQGIiT-chwQaiiFKmFA3COMom3Dcwk0yRD2X9PtruC3jhZth7brx5CngB7DQzaN18Zq6ECUTcvevmSQS9kBffICmQnKt5ycZ-s_iLH5GFKP1jpeS0ekGNgTIoGYEVuPgfvcb6KIYffzryiPnidrzCGS_TO0Ek7n9Frb5DuxnreUufpT2c9bqsctU_zqAti6ayzQ58TXZLzl_Ti4rSagg-HrbdU09mNIdOUF7t9RI42ekz4-FDX5Pvph28nZ9X5l4-fTt6fV0b0LFcdcgRukfFG6LZtoB5q3PC2EQK4hmGouazRiE60Bvqulkz3FixrBujBQifW5Pn-7hzD9YIpq8klg2PJjGFJqu1b0XDJC9jsQRNDShE3ao5u0nGrgKmdcXVrXO10ql6qW-OlW5OnhwfLMKG9s7VXXIBnB0Ano8dNUWZc-sd1ddvJpmDv9hgWG78cRpVM0WnQuogmKxvcf5L8AavunoQ</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Zanker, B</creator><creator>Rothenpieler, U</creator><creator>Kubitza, A</creator><creator>Schneeberger, H</creator><creator>Hillebrand, G</creator><creator>Land, W</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990201</creationdate><title>Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study</title><author>Zanker, B ; Rothenpieler, U ; Kubitza, A ; Schneeberger, H ; Hillebrand, G ; Land, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-7e2e12de0253a66514b4ef2653312a1bb4284ec3736c197480a9d1d05b191d173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cyclosporine - therapeutic use</topic><topic>Drug Administration Schedule</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Humans</topic><topic>Immunomodulators</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Immunosuppressive Agents - pharmacokinetics</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Transplantation - immunology</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycophenolic Acid - administration & dosage</topic><topic>Mycophenolic Acid - analogs & derivatives</topic><topic>Mycophenolic Acid - pharmacokinetics</topic><topic>Mycophenolic Acid - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Pilot Projects</topic><topic>Tissue Donors</topic><topic>Toxicity: urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zanker, B</creatorcontrib><creatorcontrib>Rothenpieler, U</creatorcontrib><creatorcontrib>Kubitza, A</creatorcontrib><creatorcontrib>Schneeberger, H</creatorcontrib><creatorcontrib>Hillebrand, G</creatorcontrib><creatorcontrib>Land, W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zanker, B</au><au>Rothenpieler, U</au><au>Kubitza, A</au><au>Schneeberger, H</au><au>Hillebrand, G</au><au>Land, W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>31</volume><issue>1-2</issue><spage>1142</spage><epage>1143</epage><pages>1142-1143</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10083511</pmid><doi>10.1016/S0041-1345(98)01938-1</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0041-1345 |
| ispartof | Transplantation proceedings, 1999-02, Vol.31 (1-2), p.1142-1143 |
| issn | 0041-1345 1873-2623 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69635282 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Aged Biological and medical sciences Cyclosporine - therapeutic use Drug Administration Schedule Drug toxicity and drugs side effects treatment Humans Immunomodulators Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - pharmacokinetics Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Medical sciences Middle Aged Mycophenolic Acid - administration & dosage Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - pharmacokinetics Mycophenolic Acid - therapeutic use Pharmacology. Drug treatments Pilot Projects Tissue Donors Toxicity: urogenital system |
| title | Nonnephrotoxic, nonatherogenic maintenance therapy in kidney-transplanted patients using MMF-monotherapy: a pilot study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A56%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonnephrotoxic,%20nonatherogenic%20maintenance%20therapy%20in%20kidney-transplanted%20patients%20using%20MMF-monotherapy:%20a%20pilot%20study&rft.jtitle=Transplantation%20proceedings&rft.au=Zanker,%20B&rft.date=1999-02-01&rft.volume=31&rft.issue=1-2&rft.spage=1142&rft.epage=1143&rft.pages=1142-1143&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/S0041-1345(98)01938-1&rft_dat=%3Cproquest_cross%3E69635282%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69635282&rft_id=info:pmid/10083511&rft_els_id=S0041134598019381&rfr_iscdi=true |